Tools

Everything Trials & Drug Resolver exposes to your AI client: tools, resources and prompts.

7 capabilities7 tool

Automated heuristic

Tool docs quality: C — 7 tools graded

Average 66/100 for how clearly each description tells an AI client what the tool does, what it needs, and what it changes. It is not a security audit.

Grade A: 0
Grade B: 4
Grade C: 3
Grade D: 0
Grade F: 0

How grades work

competitive_landscapetool
Drugs in development for a target or an indication, with mechanisms, sponsors, and trial phases. ChEMBL supplies targets and mechanisms. ClinicalTrials.gov supplies sponsors and phases. Results are capped.
Description quality grade C, 55/100 · 3 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: not passed0/20
  Say what the tool needs, for example “by issue number” or “takes a file path”.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.
drug_profiletool
One resolved drug: synonyms, identifiers, mechanisms, linked trials, and sponsors.
Description quality grade B, 75/100 · 2 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: passed20/20
  The description mentions what the tool takes.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.
find_trials_at_sitetool
CTIS trials whose authorised sites match an organisation name. Pass the name; OMS ORG- keys are not in the public search index.
Description quality grade C, 55/100 · 3 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: not passed0/20
  Say what the tool needs, for example “by issue number” or “takes a file path”.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.
get_eu_trial_sitestool
Authorised EU CTIS sites for one CT number: organisation, ORG key, address, department, city, postcode, country, principal investigator, and per-country dates. Emails and phone numbers are removed.
Description quality grade B, 75/100 · 2 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: passed20/20
  The description mentions what the tool takes.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.
resolve_drugtool
Verified UNII, ChEMBL ID, and RxCUI (when one exists), a canonical name, the match method, and a confidence flag. Combinations come back as one component each. none means the server will not guess.
Description quality grade B, 75/100 · 2 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: passed20/20
  The description mentions what the tool takes.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.
search_eu_trialstool
EU CTIS overviews by condition, sponsor, country, or public status. Country is filtered from the overview rows. Pages past the 10,000-row cap use the opposite sort.
Description quality grade C, 55/100 · 3 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: not passed0/20
  Say what the tool needs, for example “by issue number” or “takes a file path”.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.
search_trialstool
ClinicalTrials.gov v2 studies. A drug argument is resolved first and the search uses those synonyms. Duplicate NCT records are merged. Sponsor names are normalised.
Description quality grade B, 75/100 · 2 to fix
- Has a description: passed20/20
  The tool has a description an AI client can read.
- Sensible length: passed20/20
  Length is in a useful range.
- Starts with what it does: not passed0/15
  Open with an action verb, for example “Search issues…” or “Creates a label…”.
- Mentions its inputs: passed20/20
  The description mentions what the tool takes.
- Explains side effects: passed15/15
  Looks read-only, so no disclosure is required. Saying “read-only” still helps.
- Gives usage guidance: not passed0/10
  Add when to use it, what it requires, or what to use instead.